Literature DB >> 24482150

Study suggests varenicline safe and effective among adults with stable depression.

Paul M Cinciripini1, Maher Karam-Hage1.   

Abstract

Entities:  

Keywords:  Psychiatry; Public Health

Mesh：

Substances：

Year:  2014        PMID： 24482150      PMCID： PMC9387515          DOI： 10.1136/eb-2013-101619

Source DB:  PubMed          Journal:  Evid Based Med        ISSN： 1356-5524


× No keyword cloud information.
  8 in total

1.  Neuropsychiatric events in varenicline and nicotine replacement patch users in the Military Health System.

Authors:  Tamra E Meyer; Lockwood G Taylor; Suji Xie; David J Graham; Andrew D Mosholder; James R Williams; David Moeny; Rita P Ouellet-Hellstrom; Trinka S Coster
Journal:  Addiction       Date:  2012-10-18       Impact factor: 6.526

2.  The relation between nicotine dependence and suicide attempts in the general population.

Authors:  Daniel Yaworski; Jennifer Robinson; Jitender Sareen; James M Bolton
Journal:  Can J Psychiatry       Date:  2011-03       Impact factor: 4.356

3.  Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.

Authors:  Douglas E Jorenby; J Taylor Hays; Nancy A Rigotti; Salomon Azoulay; Eric J Watsky; Kathryn E Williams; Clare B Billing; Jason Gong; Karen R Reeves
Journal:  JAMA       Date:  2006-07-05       Impact factor: 56.272

Review 4.  Nicotine receptor partial agonists for smoking cessation.

Authors:  Kate Cahill; Lindsay F Stead; Tim Lancaster
Journal:  Cochrane Database Syst Rev       Date:  2012-04-18

5.  A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder.

Authors:  Jill M Williams; Robert M Anthenelli; Chad D Morris; Joan Treadow; John R Thompson; Carla Yunis; Tony P George
Journal:  J Clin Psychiatry       Date:  2012-05       Impact factor: 4.384

6.  Effects of varenicline and bupropion sustained-release use plus intensive smoking cessation counseling on prolonged abstinence from smoking and on depression, negative affect, and other symptoms of nicotine withdrawal.

Authors:  Paul M Cinciripini; Jason D Robinson; Maher Karam-Hage; Jennifer A Minnix; Cho Lam; Francesco Versace; Victoria L Brown; Jeffrey M Engelmann; David W Wetter
Journal:  JAMA Psychiatry       Date:  2013-05       Impact factor: 21.596

7.  Tobacco use disorder and the risk of suicide mortality.

Authors:  Kipling M Bohnert; Mark A Ilgen; John F McCarthy; Rosalinda V Ignacio; Frederic C Blow; Ira R Katz
Journal:  Addiction       Date:  2014-01       Impact factor: 6.526

8.  Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database.

Authors:  D Gunnell; D Irvine; L Wise; C Davies; R M Martin
Journal:  BMJ       Date:  2009-10-01
  8 in total
  1 in total

Review 1.  Nicotine receptor partial agonists for smoking cessation.

Authors:  Kate Cahill; Nicola Lindson-Hawley; Kyla H Thomas; Thomas R Fanshawe; Tim Lancaster
Journal:  Cochrane Database Syst Rev       Date:  2016-05-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.